Sign in Subscribe
Nanotechnology

Nanoparticles Show Promise in Treating Parkinson's Disease

Strategic Insights

— 1 min read

Researchers at Kocaeli University in Turkey have discovered that nanoparticles containing growth factors can effectively differentiate neural stem cells into dopaminergic neurons in vitro, offering potential therapeutic strategies for Parkinson's disease management. The team, led by Yusufhan Yazir, used poly(lactic-co-glycolic acid) nanoparticles (PLGA-NPs) loaded with Brain-Derived Neurotrophic Factor (BDNF), Glial-Derived Neurotrophic Factor (GDNF), and Transforming Growth Factor beta 3 (TGF-b3) to promote neural stem cell differentiation. The study demonstrated that these NPs were capable of crossing an in vitro blood-brain barrier model and were taken up by neural stem cells.

Key Takeaways:

  • Researchers at Kocaeli University developed poly(lactic-co-glycolic acid) nanoparticles (PLGA-NPs) loaded with different growth factors to promote neural stem cell differentiation.
  • The NPs were characterized in terms of size, zeta potential, encapsulation efficiency, and release profile, with average sizes ranging from 217.17 ± 1.37 nm to 227.37 ± 5.39 nm.
  • The NPs were tested in an in vitro differentiation model, where they successfully induced the formation of dopaminergic neurons from neural stem cells.
  • The study demonstrated that TRF-conjugated PLGA-NPs were capable of targeting and taking up neural stem cells in an in vitro blood-brain barrier model.
  • The research has potential implications for the development of therapeutic strategies for Parkinson's disease management.

Statistics:

  • The average sizes of BDNF, GDNF, and TGF-ß3 loaded PLGA-NPs were measured to be 217.17 ± 1.37, 227.37 ± 5.39, and 220.57 ± 10.10 nm, respectively.
  • The NPs exhibited a homogeneous size distribution and smooth surface morphology.
  • Microtubule-associated protein 2 (Map2) and tyrosine hydroxylase (TH), two dopaminergic neuronal markers, were found in cells with neuron-like morphology produced through in vitro differentiation.

Sources:

  • NewsRx. Reports Summarize Nanoparticles Findings from Kocaeli University (The Effects of PLGA Nanoparticles Containing Different Growth Factors on Neural Stem Cell Differentiation and Their Transition Efficiency After Targeting With TRF). Drug Week. September 19, 2025; p 4826.
  • The Effects of PLGA Nanoparticles Containing Different Growth Factors on Neural Stem Cell Differentiation and Their Transition Efficiency After Targeting With TRF. CNS Neuroscience & Therapeutics, 2025;31(9).

Read more